The prospect of targeting inflammation to treat residual cardiovascular risk using the monoclonal antibody canakinumab (Ilaris) appears to be slim to none in the wake of recent decisions from ...
We analysed the past 20 years of drug project history with the aim of understanding more about how the pharmaceutical industry has been performing with regard to therapeutic mechanisms and their ...
U.S. Occupational Safety and Health Administration (OSHA) reporting requires companies to track metrics like total recordable incident rate (TRIR), lost time incident rate (LTIR), and workers’ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results